Option Care Health, Inc. (NASDAQ:OPCH) Receives $33.75 Average PT from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has earned an average rating of “Moderate Buy” from the eight brokerages that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $35.50.

Several analysts have issued reports on OPCH shares. Barrington Research restated an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday. JMP Securities restated a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a report on Tuesday, April 22nd. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Finally, UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $38.00 to $40.00 in a research note on Wednesday.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the company’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.64% of the company’s stock.

Institutional Trading of Option Care Health

A number of hedge funds have recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp bought a new position in Option Care Health in the fourth quarter worth about $26,000. UMB Bank n.a. increased its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC increased its holdings in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after acquiring an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC increased its holdings in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock valued at $40,000 after acquiring an additional 1,099 shares in the last quarter. Finally, Public Employees Retirement System of Ohio increased its holdings in shares of Option Care Health by 21.6% during the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after acquiring an additional 332 shares in the last quarter. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Stock Up 5.3 %

Option Care Health stock opened at $32.31 on Monday. The firm has a 50 day simple moving average of $33.34 and a 200 day simple moving average of $28.82. The firm has a market capitalization of $5.31 billion, a price-to-earnings ratio of 27.15, a P/E/G ratio of 2.30 and a beta of 1.07. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 1-year low of $21.39 and a 1-year high of $35.53.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same period in the previous year, the business earned $0.26 EPS. The business’s revenue for the quarter was up 16.3% on a year-over-year basis. On average, analysts predict that Option Care Health will post 1.22 earnings per share for the current year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.